NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Morphle Labs

Morphle Labs

Private
BangaloreHealthcare & Life Scienceshttps://morphlelabs.com/

Last Round

Series A

Nov 25, 2025

Est. Valuation

$1.79M

Total Funding Raised

$10.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Morphle Labs is a medical device company that develops AI-powered robotic microscopes and digital pathology scanners to automate tissue processing and slide scanning for cancer diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

digital pathologyrobotic microtomewhole slide imagingtelepathologymedical imaginghistopathologylab automationcancer diagnosticsmedical AIpathology scannerpathology lab automationsmart labmedical deviceAI diagnosticspathology workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Morphle Labs Comps

Public and private peers based on sector, stage, and business model.

Morphle Labs comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Morphle Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 25, 2025
Series ANov 25, 2023
SeedMar 17, 2020
GrantDec 16, 2019

Key People

Founding team and executive leadership

Rohit Hiwale

Founder CEO

Founding Team

Sunnel Daniel

Chief Operating Officer, Vice President Of Sales

Executive Team

Morphle Labs Investors

Notable investors and investment history

Morphle Labs investors
InvestorRounds
Enzia VenturesSeed
HealthVentureGrant
Y CombinatorSeed
Inflexor VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 5, 2025

    Claims market leadership in India with global customer growth.

  • Nov 25, 2025

    $5M round completed.

Morphle Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Morphle Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Morphle Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range105
Year Founded2017
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.